Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

AHF: TV Ad Blasts Bill by Congressman Peters (D-CA) Hurting Nonprofits

AIDS Healthcare Foundation
Posted on: 19 Jan 18

Drug pricing advocates from AIDS Healthcare Foundation (AHF) have rolled out a new TV and radio ad campaign in the San Diego market blasting Congressman Scott Peters (D-CA 52nd District) for sponsoring a bill that would severely curtail nonprofit hospitals’ participation in the 340B program, a federally-administered drug discount pricing program created to extend the lifeline of care and services that safety net hospitals and providers are able to deliver. Peters, a San Diego Democrat, co-sponsored the bill with Rep. Larry Bucshon (R-IN).

Days before the December Congressional Recess and with little to no public input or scrutiny, he and Bucshon introduced H.R. 4710, a misguided bill pushed by pharmaceutical industry lobbyists that will gut the federally-administered drug discount program—a program that costs the government and taxpayers nothing. Advocates assert the bill, should it pass into law, will significantly reduce healthcare access for people—including many of those in Peters’ own San Diego district.

The radio and cable television campaign in San Diego includes 264 radio spots running on KXSN (98.1 FM), KYXY (96.5 FM) and KMYI (Star 94.1 FM) as well as a ‘Let340B!’ television ad running on San Diego area Cox Cable channels. The TV ad urges Peters’ constituents to contact him to demand that he not harm the drug pricing program by continuing to back this bill. The TV ad will run for a two-week flight (Jan 15-28) and will run as more than 700 spots across different Cox channels in the San Diego market.

“H.R. 4710 is really a brazen attack on the poor being falsely characterized as ‘reform.’ It is a full-on assault being led by the pharmaceutical industry and their lobbyists and friends in Congress, like Congressman Peters,” said Michael Weinstein, President of AIDS Healthcare Foundation. “In reality, this is a very worthwhile and lifesaving drug pricing program that costs the government and taxpayers nothing. 340B is continually in the crosshairs of Big Pharma and their legislative friends. However, we’ve seen that the public is wise enough to know that if pharma is involved in any drug pricing issue, they—the public or the patient—is on the losing side. We will continue to fight back against attacks on 340B and urge Congressman Peters to reconsider his sponsorship of this dangerous bill.”

Peters, who has served in Congress since 2013 and is the sixth wealthiest member of Congress, has taken in more that $100,000 in contributions from the drug and biotech industries while in Congress.

About the 340B Program

The 340B program was enacted by Congress as part of the Veterans Health Care Act of 1992 to allow designated safety net medical providers, called “covered entities”, to purchase prescription outpatient drugs directly from pharmaceutical manufacturers at discounted prices. As a discount program, 340B costs federal taxpayers and the government nothing. Congress itself expressed that the goal of the program is “to enable [covered entities] to stretch scarce Federal resources as far as possible, reaching more eligible patients and providing more comprehensive services.”1

To view a short explainer video about what the 340B program is and how it impacts the lives of ordinary Americans, click here. For more information on the campaign to preserve 340B, please visit www.Let340B.org.

AIDS Healthcare Foundation (AHF), the largest global AIDS organization, currently provides medical care and/or services to over 855,000 individuals in 39 countries worldwide in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region and Eastern Europe. To learn more about AHF, please visit our website: www.aidshealth.org, find us on Facebook: www.facebook.com/aidshealth and follow us on Twitter: @aidshealthcare.

1 House Report No. 102–384(II), September 22, 1992, Page 12.

View source version on businesswire.com: http://www.businesswire.com/news/home/20180119005604/en/

Business Wire
www.businesswire.com

Last updated on: 19/01/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.